Insider Sell: Moderna
© MT Newswires 2022
All news about MODERNA, INC. |
|
12:25p | Moderna's CEO Stephane Bancel to Exercise Shares, Intends to Donate Proceeds to Charity | MT |
12:13p | GLOBAL MARKETS LIVE : Broadcom, Airbnb, Roche, Toyota, Uber | |
10:48a | WALL STREET STOCK EXCHANGE : Snap cut the rally short | |
09:26a | Rubius Therapeutics Names Noubar Afeyan Chairman; Shares Rise Pre-Bell | MT |
09:15a | TRANSCRIPT : Moderna, Inc. Presents at UBS Global Healthcare Conference, May-24-2022 09:15.. | CI |
08:03a | MODERNA, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K) | AQ |
07:44a | Moderna testing potential monkeypox vaccines | RE |
06:41a | Moderna CEO to Exercise 2013 Option, Donate Funds to Charity | DJ |
01:08a | China's bet on homegrown mRNA vaccines holds back nation | AQ |
05/23 | MODERNA : Statement Regarding Section 1498 Motion | PU |
|
|
Analyst Recommendations on MODERNA, INC. |
|
|
| |
|
Sales 2022 |
22 069 M
-
-
|
Net income 2022 |
11 501 M
-
-
|
Net cash 2022 |
18 081 M
-
-
|
P/E ratio 2022 |
5,06x |
Yield 2022 |
- |
|
Capitalization |
54 740 M
54 740 M
-
|
EV / Sales 2022 |
1,66x |
EV / Sales 2023 |
3,38x |
Nbr of Employees |
2 700 |
Free-Float |
90,6% |
|
|
Duration :
Period :
|
 |
|
Technical analysis trends MODERNA, INC.
| Short Term | Mid-Term | Long Term | Trends | Neutral | Bearish | Bearish |
Income Statement Evolution
|
Mean consensus |
OUTPERFORM |
Number of Analysts |
19 |
Last Close Price |
137,62 $ |
Average target price |
212,69 $ |
Spread / Average Target |
54,5% |
|